​

Funding Round

Series A - Shield Bio

Series A - Shield Bio

Investment Firm

Overview

Shield Bio - using ultra-fast sequencing to prevent antibiotic resistance

Announced Date

May 23, 2018

Closed on Date

May 11, 2018

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Andreessen Horowitz

Andreessen Horowitz

Andreessen Horowitz is a early_stage_venture and late_stage_venture and seed and venture firm.

Refactor

Refactor

Refactor is a early_stage_venture and seed firm.

Participant Investors

15

Investor Name
Participant InvestoriSelect Fund
Participant InvestorChris Anderson
Participant InvestorSean Rad
Participant InvestorAndreessen Horowitz
Participant InvestorY Combinator

Round Details and Background

Shield Bio raised $8000000 on 2018-05-23 in Series A

Shield Bio - using ultra-fast sequencing to prevent antibiotic resistance

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 23, 2017
Seed Round - Shield Bio
7-4.1M
Apr 01, 2019
Pre Seed Round - Shield Bio
-undefined
May 23, 2018
Series A - Shield Bio
19-8.0M

Recent Activity

There is no recent news or activity for this profile.